## Abstract ## Background One of the drawbacks of the currently available vectors for gene therapy is the lack of selectivity in gene delivery. We have therefore investigated a strategy to generate immunoliposomes to target nonβviral vectors to cell surface receptors on endothelium. ## Materials
β¦ LIBER β¦
Antibodies: from genes to targeted cancer gene therapy
β Scribed by Hawkins, R E; Whittington, H A; Watkins, S J; Gilham, D E
- Book ID
- 110038331
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 57 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0969-7128
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Antibody targeted gene transfer to endot
β
P. H. Tan; M. Manunta; N. Ardjomand; S. A. Xue; D. F. P. Larkin; D. O. Haskard;
π
Article
π
2003
π
John Wiley and Sons
π
English
β 343 KB
Papillomaviruses as targets for cancer g
β
Shillitoe, E J
π
Article
π
2005
π
Nature Publishing Group
π
English
β 128 KB
Gene targeting: Roadmap to future therap
β
Lars C. Huber; Thomas Pap; Ulf MΓΌller-Ladner; Renate E. Gay; Steffen Gay
π
Article
π
2004
π
Springer
π
English
β 166 KB
Targeting gene therapy to airway epithel
β
Sinclair, Meeghan
π
Article
π
2000
π
Nature Publishing Group
π
English
β 127 KB
Gene therapy targeting to tumor endothel
β
Bazan-Peregrino, M; Seymour, L W; Harris, A L
π
Article
π
2006
π
Nature Publishing Group
π
English
β 225 KB
Pharmacological aspects of targeting can
β
H.H. Sedlacek
π
Article
π
2001
π
Elsevier Science
π
English
β 350 KB
Targeting cancer gene therapy to endothelial cells seems to be a rational approach, because (a) a clear correlation exists between proliferation of tumor vessels and tumor growth and malignancy, (b) differences of cell membrane structures between tumor endothelial cells and normal endothelial cells